Illumina Gets $1.2M From NCI to Build Protein Immunoassay Platform

Mar 12, 2002

NEW YORK, March 12 - Illumina will be getting $1.2 million from the National Cancer Institute to develop a multiplexed immunoassay system for proteins and post-translational protein modifications, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Sema4 Partners With PWNHealth on Consumer Genetic Testing
Top Five Articles on GenomeWeb Last Week: Genentech, Bio-Rad, Thermo Fisher, and More
Tempus Raises $70M in Series C Financing Round
CMS 2018 PAMA Pricing Cut for Lab Tests Deeper Than Prior Estimate; Advanced Dx Lab Tests Fare Well
FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications
In Brief This Week: Agilent, Edico Genome, Alere, and More

The Scan

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu